BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2591453)

  • 21. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
    J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-myc amplification in an infant with stage IVS neuroblastoma.
    Cohn SL; Herst CV; Maurer HS; Rosen ST
    J Clin Oncol; 1987 Sep; 5(9):1441-4. PubMed ID: 3625259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-myc oncogene RNA expression in neuroblastoma.
    Nisen PD; Waber PG; Rich MA; Pierce S; Garvin JR; Gilbert F; Lanzkowsky P
    J Natl Cancer Inst; 1988 Dec; 80(20):1633-7. PubMed ID: 2461451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Study Group of Japan for Treatment of Advanced Neuroblastoma, Tokyo, Japan.
    Kaneko M; Nishihira H; Mugishima H; Ohnuma N; Nakada K; Kawa K; Fukuzawa M; Suita S; Sera Y; Tsuchida Y
    Med Pediatr Oncol; 1998 Jul; 31(1):1-7. PubMed ID: 9607422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-myc amplification and cell proliferation rate in human neuroblastoma.
    Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
    J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.
    van Wezel EM; Decarolis B; Stutterheim J; Zappeij-Kannegieter L; Berthold F; Schumacher-Kuckelkorn R; Simon T; Fiocco M; van Noesel MM; Caron HN; van der Schoot CE; Hero B; Tytgat GAM
    Eur J Cancer; 2016 Feb; 54():149-158. PubMed ID: 26796600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma.
    Tonini GP; Verdona G; Garaventa A; Cornaglia-Ferraris P
    Anticancer Res; 1987; 7(4B):729-32. PubMed ID: 3314672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
    Seeger RC; Brodeur GM; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
    N Engl J Med; 1985 Oct; 313(18):1111-6. PubMed ID: 4047115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of N-myc amplification with neuroblastoma: the Australian and New Zealand experience.
    Telford DJ; Kavallaris M; White L; Norris MD; Brian MJ; Stewart BW
    J Paediatr Child Health; 1992 Feb; 28(1):58-63. PubMed ID: 1554517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
    Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M
    Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables.
    Oppedal BR; Oien O; Jahnsen T; Brandtzaeg P
    J Clin Pathol; 1989 Nov; 42(11):1148-52. PubMed ID: 2584426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
    Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
    Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-myc oncogene amplification and prognostic factors of neuroblastoma in children.
    Nakagawara A; Ikeda K; Tsuda T; Higashi K
    J Pediatr Surg; 1987 Oct; 22(10):895-8. PubMed ID: 3316592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
    Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP
    Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
    J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
    Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
    J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
    Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
    Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of the MYCN oncogene in neuroblastoma.
    Theissen J; Boensch M; Spitz R; Betts D; Stegmaier S; Christiansen H; Niggli F; Schilling F; Schwab M; Simon T; Westermann F; Berthold F; Hero B
    Clin Cancer Res; 2009 Mar; 15(6):2085-90. PubMed ID: 19276282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar chromosomal patterns and lack of N-myc gene amplification in localized and IV-S stage neuroblastomas in infants.
    Hayashi Y; Inaba T; Hanada R; Yamada M; Nakagome Y; Yamamoto K
    Med Pediatr Oncol; 1989; 17(2):111-5. PubMed ID: 2704332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. myc gene amplification and expression in primary human neuroblastoma.
    Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR
    Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.